Suchergebnisse - "Oliva, Stefania"

PubPharm (67)

1

What is the best treatment strategy before autologous peripheral blood stem cell transplantation in POEMS syndrome?

enthalten in: Haematologica | 2024

von Autore, F. | Bramanti, S. | Lessi, F. | +18

2

Predictors of unsustained measurable residual disease negativity in patients with multiple myeloma

enthalten in: Blood | 2024

von D'Agostino, M. | Bertuglia, G. | Rota-Scalabrini, D. | +22

CommentIn: Blood. 2024 Feb 15;143(7):564-566. - PMID 38358852

3

A Hospital Medical Record Quality Scoring Tool (MeReQ) : Development, Validation, and Results of a Pilot Study

enthalten in: Healthcare (Basel, Switzerland) | 2024

von Torsello, A. | Aromatario, M. | Scopetti, M. | +4

4

Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma

enthalten in: bioRxiv.org | 2023

von Ziccheddu, B. | Giannotta, C. | D’Agostino, M. | +15

5

Genomic and immune determinants of resistance to anti-CD38 monoclonal antibody-based therapy in relapsed refractory multiple myeloma

enthalten in: medRxiv : the preprint server for health sciences | 2023

von Ziccheddu, B. | Giannotta, C. | D'Agostino, M. | +15

6

Introducing Telemedicine in Italy : Citizens' Awareness of a New Healthcare Resource

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Gallè, F. | Oliva, S. | Covelli, E. | +5

7

Efficacy and safety of isatuximab plus bortezomib, lenalidomide, and dexamethasone in patients with newly diagnosed multiple myeloma ineligible/with no immediate intent for autologous stem cell transplantation

enthalten in: Leukemia | 2023

von Ocio, E. | Perrot, A. | Bories, P. | +18

8

Prospective evaluation of minimal residual disease in the phase II FORTE trial : a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing

enthalten in: EClinicalMedicine | 2023

von Oliva, S. | Genuardi, E. | Paris, L. | +22

9

Impact of minimal residual disease standardised assessment by FDG-PET/CT in transplant-eligible patients with newly diagnosed multiple myeloma enrolled in the imaging sub-study of the FORTE trial

enthalten in: EClinicalMedicine | 2023

von Zamagni, E. | Oliva, S. | Gay, F. | +28

10

Collective Catering Activities and Official Controls : Dietary Promotion, Sustainability and Future Perspectives

enthalten in: Healthcare (Basel, Switzerland) | 2023

von Marcotrigiano, V. | Stingi, G. | Nugnes, P. | +12

1
2
3
4
5
6
7
Nächster »
[7]